Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT05994157 |
Title | Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma |
Recruitment | Not yet recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Y-mAbs Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
HonorHealth | Scottsdale | Arizona | 85258 | United States | Details | |
City of Hope | Duarte | California | 91010 | United States | Details | |
Corewell Health-BAMF Health | Grand Rapids | Michigan | 49503 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Stony Brook Cancer Center | Stony Brook | New York | 11794 | United States | Details | |
East Carolina University Leo W. Jenkins Cancer Center | Greenville | North Carolina | 27834 | United States | Details |